Shire Pharmaceuticals Group

Shire Pharmaceuticals Group plc is a British manufacturer of pharmaceuticals including Adderall XR, Carbatrol, and Fosrenol. Founded in 1986, Shire had revenues for the full year 2004 of $1,363.2 million and an operating income of $446.4 million. The growth rates for revenues were 13% for 2004 over the prior year. ^*

Corporate Strategy

Shire’s strategic goal is to become the leading specialty pharmaceutical company, focusing on meeting the needs of specialist physicians. Shire believes that a carefully selected portfolio of products with a strategically aligned and relatively small-scale sales force will deliver strong results. To this end, Shire focuses its business on medications in the areas of central nervous system (CNS), gastrointestinal (GI), general products (GP) and human genetic therapies (HGT), all areas where Shire currently has a commercial presence.

The structure is sufficiently flexible to allow Shire to target new therapeutic areas through acquisitions. This approach aims to deliver increased returns and lower risks. Shire’s in-licensing and merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the U.S. or Europe.

Corporate Leadership

Matthew Emmens is the Chief Executive Officer and Chairman of the Executive Committee. The non-executive Board Chairman is Dr. James Cavanaugh.

Key Marketed Products and Indications

Adderall XR: Attention Deficit Hyperactivity Disorder
Adderall: Attention Deficit Hyperactivity Disorder
Carbatrol: Epilepsy
Colazol: Ulcerative Colitis
Equetro: Bipolar I Mood Disorder
Fosrenol: Hyperphosphatemia associated with End-Stage Renal Disease
Pentasa: Ulcerative Colitis
Reminyl (also sold as Razadyne): Alzheimer's Disease
Xagrid (sold as Agrylin in the U.S.): Essential Thrombocytosis

Financial Information

Shire is traded on three stock exchanges:

The London Stock Exchange, where its symbol is SHP.L. Shire is a constituent of the FTSE 100 Index.
The NASDAQ, where its symbol is SHPGY.
The Toronto Stock Exchange, where its symbol is SHQ.TO.

Shire's financial reports can be found at http://www.shire.com/shire/InvestorRelations/reports.jsp?tn=2&m1=22.

Locations

The corporate offices are located in Basingstoke, Hampshire. The address is:

Hampshire International Business Park

Chineham Basingstoke

Hampshire

RG24 8EP

United Kingdom

Other major offices are located in the United States in Wayne, Pennsylvania and Cambridge, Massachusetts. Plus, Shire owns a manufacturing site in Owings Mills, Maryland.

External links

Pharmaceutical companies of the United Kingdom | Companies listed on the London Stock Exchange | Companies listed on NASDAQ | Companies in the NASDAQ Biotechnology Index | Biotechnology companies

Shire Pharmaceuticals